查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611988

急性缺血性脑中风诊断市场：按产品类型、测试类型、疾病类型、技术、最终用户 - 全球预测 2025-2030

Acute Ischemic Stroke Diagnosis Market by Product Type (Blood Biomarker, Carotid Ultrasound, Diagnostic Imaging), Test Type (Imaging Tests, Lab Tests), Disease Type, Technology, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，急性缺血性脑中风诊断市值为35.7亿美元，预计到2024年将达到37.7亿美元，复合年增长率为6.61%，到2030年将达到55.9亿美元。

急性缺血性脑中风诊断主要着重于识别和评估因脑部血流受限而引起的缺血性中风患者。准确、快速诊断的需求源于中风治疗的紧迫性，其中时间对于恢復血流和最大程度地减少脑损伤至关重要。应用范围涵盖急诊室、医院和中风中心，重点是先进的影像技术，例如 CT 和 MRI 扫描，以区分缺血性和出血性中风。该市场为医疗保健专业人员、医院、研究机构和医疗设备製造商提供设备和诊断工具。影响成长的关键因素包括由于老化和生活方式的改变而导致中风盛行率增加、影像技术的进步以及医疗保健基础设施的改善。然而，诊断设备的高成本和医疗保健差异是市场成长的阻碍因素。市场开拓机会包括开发便携式且易于使用的诊断技术、使用人工智慧进行早期检测、远端医疗以及扩展到卫生系统服务不足的新兴市场。投资研究非侵入性诊断工具和人工智慧演算法的公司可能会获得竞争优势。然而，必须解决诸如需要专业劳动力、监管障碍以及与人工智慧整合相关的资料隐私问题等挑战。从业务成长的角度来看，创新可以专注于增强诊断系统的互通性，提高诊断的准确性和速度，以及探索与数位健康新兴企业的合作关係。市场的特征是技术快速发展和竞争压力，企业需要不断创新来维持市场地位。为了实现最佳业务成长，相关人员正在强调策略联盟、对最尖端科技的投资以及针对特定区域需求的市场扩张倡议，以利用急性缺血性脑中风诊断市场的潜在机会。

主要市场统计
基准年[2023] 35.7亿美元
预计年份 [2024] 37.7亿美元
预测年份 [2030] 55.9亿美元
复合年增长率（%） 6.61%

市场动态：快速发展的急性缺血性脑中风诊断市场的关键市场洞察

供应和需求的动态交互作用正在改变急性缺血性脑中风诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 心肌梗塞发生率不断增加，对先进诊断工具的需求不断增加
    • 扩大发展中地区医疗基础建设投资
    • 提高人们对及时医疗介入和早期诊断检测重要性的认识
  • 市场限制因素
    • 发展中地区诊断程序高成本且获得先进医疗服务的机会有限
  • 市场机会
    • 整合机器人技术和人工智慧进行进阶诊断
    • 远端医疗服务的进步促进远距离诊断和早期疗育
  • 市场挑战
    • 缺乏熟练的医疗保健专业人员

波特的五力：驾驭急性缺血性脑中风诊断市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解急性缺血性脑中风诊断市场的外部影响

外部宏观环境因素在塑造急性缺血性脑中风诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解急性缺血性脑中风诊断市场的竞争模式

对急性缺血性脑中风诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵急性缺血性脑中风诊断市场供应商的绩效评估

FPNV 定位矩阵是评估急性缺血性脑中风诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划急性缺血性脑中风诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对急性缺血性脑中风诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心臟病发生率增加，先进诊断工具的需求增加
      • 增加对发展中地区医疗基础建设的投资
      • 提高人们对及时医疗介入和早期诊断检测重要性的认识
    • 抑制因素
      • 发展中地区诊断程序成本高且获得先进医疗保健的机会有限
    • 机会
      • 整合机器人和人工智慧进行进阶诊断
      • 远端医疗服务的进步促进远距离诊断和早期疗育
    • 任务
      • 缺乏熟练的卫生保健人员
  • 市场区隔分析
    • 产品类型：增加血液生物标记的使用以早期检测脑损伤
    • 最终用途：对住院服务进行强化监测的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章急性缺血性脑中风诊断市场：依产品类型

  • 血液生物标记
  • 颈动脉超音波检查
  • 诊断影像
    • 电脑断层扫描 (CT) 扫描仪
    • 核磁共振系统
  • 脑电图测试

第七章按测试类型分類的急性缺血性脑中风诊断市场

  • 影像检查
  • 实验室筛检
    • 验血
    • 代谢组

第八章急性缺血性脑中风诊断市场：依疾病类型

  • 栓塞
  • 空白
  • 血栓形成

第九章急性缺血性脑中风诊断市场：依技术分类

  • 基于生物标记的检测
  • 就地检验

第 10 章急性缺血性脑中风诊断市场：依最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院
    • 住院病人
    • 门诊病人
  • 调查机构

第十一章北美和南美急性缺血性脑中风诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区急性缺血性脑中风诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲急性缺血性脑中风诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • StrokeDx 获得 500 万美元资金，用于加强非侵入性中风侦测技术并扩大市场覆盖范围
    • 中国医科大学附属医院的AISIA人工智慧平台透过快速、准确、灵敏的深度学习模型彻底改变了缺血性中风诊断，改善了患者的治疗效果并降低了长期成本。
    • CERENOVUS 推出采用 TruCourse 技术的 CEREGLIDE 71 中间导管，为急性缺血性脑中风治疗的进步做出贡献
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies Inc.
  • Genentech, Inc. by Roche Group
  • Hitachi, Ltd.
  • Integral Diagnostics（IDX）Group
  • Koninklijke Philips NV
  • Mediso Kft.
  • Medtronic PLC
  • Memorial Health
  • Neusoft Medical Systems Co., Ltd.
  • Nihon Kohden Corporation
  • Planmed Oy
  • Samsung Electronics Co. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers company
  • Stryker Corporation
  • Toshiba International Corporation
Product Code: MRR-B16853776EA8

The Acute Ischemic Stroke Diagnosis Market was valued at USD 3.57 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 6.61%, to USD 5.59 billion by 2030.

The scope of acute ischemic stroke diagnosis involves identifying and evaluating patients experiencing ischemic strokes, primarily caused by blockages restricting blood flow to the brain. The necessity for accurate and rapid diagnosis stems from the urgent nature of stroke treatment, where time is critical to restore blood flow and minimize brain damage. The applications extend to emergency departments, hospitals, and specialized stroke centers, focusing on advanced imaging technologies like CT and MRI scans to differentiate between ischemic and hemorrhagic strokes. This market serves healthcare professionals, hospitals, research institutions, and medical device manufacturers with equipment and diagnostic tools. Key factors influencing growth include the increasing prevalence of strokes due to aging populations and lifestyle changes, advancements in imaging technology, and improved healthcare infrastructure. However, the high cost of diagnostic equipment and healthcare disparities pose limitations to market growth. Opportunities lie in the development of portable and accessible diagnostic technologies, use of artificial intelligence for early detection, telemedicine, and expansion into emerging markets with inadequate healthcare systems. Companies investing in research for non-invasive diagnostic tools and AI algorithms may gain competitive advantages. Nonetheless, challenges such as the need for specialized workforce, regulatory hurdles, and data privacy issues related to AI integration must be addressed. Innovation from a business growth perspective could focus on enhancing the interoperability of diagnostic systems, improving accuracy and speed of diagnosis, and exploring partnerships with digital health startups. The market is characterized by rapid technological evolution and competitive pressures requiring companies to continuously innovate to maintain market positions. For optimal business growth, stakeholders should emphasize strategic collaborations, investment in cutting-edge technologies, and market expansion initiatives tailored to specific regional demands to harness the full potential of opportunities in the acute ischemic stroke diagnosis market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.57 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 5.59 billion
CAGR (%) 6.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute Ischemic Stroke Diagnosis Market

The Acute Ischemic Stroke Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cardiac strokes, enhancing need for advanced diagnostic tools
    • Growing investment in healthcare infrastructure in developing regions
    • Rising awareness about the importance of timely medical intervention and earlier diagnostic testing
  • Market Restraints
    • High cost of diagnostic procedures and limited access to advanced healthcare in developing regions
  • Market Opportunities
    • Integration of robotics and AI for advanced diagnostics
    • Advancement in telemedicine services facilitating remote diagnosis and early intervention
  • Market Challenges
    • Shortage of skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Acute Ischemic Stroke Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute Ischemic Stroke Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute Ischemic Stroke Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute Ischemic Stroke Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute Ischemic Stroke Diagnosis Market

A detailed market share analysis in the Acute Ischemic Stroke Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute Ischemic Stroke Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute Ischemic Stroke Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute Ischemic Stroke Diagnosis Market

A strategic analysis of the Acute Ischemic Stroke Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Genentech, Inc. by Roche Group, Hitachi, Ltd., Integral Diagnostics (IDX) Group, Koninklijke Philips N.V., Mediso Kft., Medtronic PLC, Memorial Health, Neusoft Medical Systems Co., Ltd., Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, Stryker Corporation, and Toshiba International Corporation.

Market Segmentation & Coverage

This research report categorizes the Acute Ischemic Stroke Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Blood Biomarker, Carotid Ultrasound, Diagnostic Imaging, and Electroencephalography. The Diagnostic Imaging is further studied across Computed Tomography (CT) Scanner and MRI System.
  • Based on Test Type, market is studied across Imaging Tests and Lab Tests. The Lab Tests is further studied across Blood Test and Metabolic Panel.
  • Based on Disease Type, market is studied across Embolic, Lacunar, and Thrombotic.
  • Based on Technology, market is studied across Biomarker-Based Detection and Point Of Care Testing.
  • Based on End Users, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Institutes. The Hospitals is further studied across Inpatient and Outpatient.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiac strokes, enhancing need for advanced diagnostic tools
      • 5.1.1.2. Growing investment in healthcare infrastructure in developing regions
      • 5.1.1.3. Rising awareness about the importance of timely medical intervention and earlier diagnostic testing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diagnostic procedures and limited access to advanced healthcare in developing regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of robotics and AI for advanced diagnostics
      • 5.1.3.2. Advancement in telemedicine services facilitating remote diagnosis and early intervention
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing usage of blood biomarkers for early detection of brain injury
    • 5.2.2. End Use: Rising need of inpatient services for intensive monitoring
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute Ischemic Stroke Diagnosis Market, by Product Type

  • 6.1. Introduction
  • 6.2. Blood Biomarker
  • 6.3. Carotid Ultrasound
  • 6.4. Diagnostic Imaging
    • 6.4.1. Computed Tomography (CT) Scanner
    • 6.4.2. MRI System
  • 6.5. Electroencephalography

7. Acute Ischemic Stroke Diagnosis Market, by Test Type

  • 7.1. Introduction
  • 7.2. Imaging Tests
  • 7.3. Lab Tests
    • 7.3.1. Blood Test
    • 7.3.2. Metabolic Panel

8. Acute Ischemic Stroke Diagnosis Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Embolic
  • 8.3. Lacunar
  • 8.4. Thrombotic

9. Acute Ischemic Stroke Diagnosis Market, by Technology

  • 9.1. Introduction
  • 9.2. Biomarker-Based Detection
  • 9.3. Point Of Care Testing

10. Acute Ischemic Stroke Diagnosis Market, by End Users

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals
    • 10.4.1. Inpatient
    • 10.4.2. Outpatient
  • 10.5. Research Institutes

11. Americas Acute Ischemic Stroke Diagnosis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. StrokeDx secures USD 5M funding to enhance non-invasive stroke detection technology and expand market reach
    • 14.3.2. China Medical University Hospital's AISIA AI platform revolutionizes ischemic stroke diagnosis with rapid, accurate, and sensitive deep learning models, enhancing patient outcomes and reducing long-term costs
    • 14.3.3. CERENOVUS launches CEREGLIDE 71 Intermediate Catheter with TruCourse technology, advancing acute ischemic stroke treatment
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BIOTRONIK SE & Co KG
  • 3. Boehringer Ingelheim International GmbH
  • 4. Boston Scientific Corporation
  • 5. Canon Medical Systems Corporation
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Fujifilm Holdings Corporation
  • 8. GE Healthcare Technologies Inc.
  • 9. Genentech, Inc. by Roche Group
  • 10. Hitachi, Ltd.
  • 11. Integral Diagnostics (IDX) Group
  • 12. Koninklijke Philips N.V.
  • 13. Mediso Kft.
  • 14. Medtronic PLC
  • 15. Memorial Health
  • 16. Neusoft Medical Systems Co., Ltd.
  • 17. Nihon Kohden Corporation
  • 18. Planmed Oy
  • 19. Samsung Electronics Co. Ltd.
  • 20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 21. Shimadzu Corporation
  • 22. Siemens Healthineers company
  • 23. Stryker Corporation
  • 24. Toshiba International Corporation

LIST OF FIGURES

  • FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD BIOMARKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CAROTID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY MRI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY EMBOLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LACUNAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY THROMBOTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BIOMARKER-BASED DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 175. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 183. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 200. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 232. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 240. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 248. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 256. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 264. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 272. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 280. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 288. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 296. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 304. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 312. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS M